Expression of human PON1 decreases superoxide levels in the gut of <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

PF treatment decreases the mRNA expressions of TNFα (A) and IL-1β (B) in the brain. by Ruo-Bing Guo (298949)

Inhibition of ADAM10 or γ-secretase decreases the abundance of endogenous Fe65 in the nuclear fraction. by Niina A. Koistinen (3850717)

Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

“…Cells receiving combination therapy had a significant decrease in proliferation compared to cells treated with LG only at 24, 48, and 72 hours, and compared to βHB only at 48, 72, and 96 hours, and exhibited a non-significant trend of decreased proliferation compared to LG + HBOT treated cells for the duration of the growth curve. …”

Data_Sheet_1_A de novo Mutation in the MTUS1 Gene Decreases the Risk of Non-compaction of Ventricular Myocardium via the Rac1/Cdc42 Pathway.pdf by Xuehan Bai (6901679)

“…</p><p>Aims: To investigate the association between a de novo c. 2617A->C mutation in MTUS1 (NM_001001924.2) and non-compaction of ventricular myocardium (NVM) and explore the potential mechanisms.…”

Surviving female mice born from DIO or lean dams display a small decrease in rate of intake. by Pedro A. Perez (5807615)

“…WD offspring had higher body mass at time of wean but body weights were rapidly normalized over the monitoring period (a). There were no differences meal size (a) but slight decrease in rate of intake between groups (b). …”

CC genotype of rs7120118 variation associates with decreased soluble Aβ42 levels in the temporal cortex. by Teemu Natunen (398069)

“…<p>(A) The distribution of rs7120118 genotypes in subgroups divided by the severity of the disease (mild n = 19/18/9; moderate n = 4/4/5; severe n = 10/12/2, rs7120118 genotypes TT/CT/CC, respectively). …”

Methamphetamine exposure decreases midbrain neuronal activity via a D₂ receptor mechanism. by Douglas R. Miller (7406591)

Exogenous recombinant heparanase (rHPSE) decreases nuclear syndecan-1 levels in a concentration-dependent manner. by Ligong Chen (259976)

Inhibition of SHP-2 activity decreases <i>C</i>. <i>parvum</i> infectivity. by Eunice A. Varughese (824701)

“…<p>A) Dose-dependent decrease of Infections per field of view (y-axis) after treatment of FHs 74 Int cells with increasing concentrations of the SHP-2-specific inhibitor, SHP-2 PTPase Inhibitor. …”

CcpA inactivation significantly decreases GAS virulence and affects GAS virulence gene expression during infection. by Samuel A. Shelburne (251582)

Rapamycin inhibits mTOR and decreases Aβ₄₂ levels in brains of PDAPP mice. by Patricia Spilman (365919)

“…<b>a–c</b>, Levels of phosphorylated (activated) p70 were decreased in brains of rapamycin-treated non-transgenic (<b>a</b>) and transgenic PDAPP (<b>b</b>) mice (<b>c</b>, **, <i>P</i> = 0.006 and *, <i>P</i> = 0.01 respectively). …”

Compared to vorinostat, M344 decreases pancreatic cancer cell proliferation more effectively for a longer duration. by Shelby M. Knoche (13833807)

Deletion of <i>ERG251-A</i> but not <i>ERG251-B</i> leads to decreased filamentation. by Xin Zhou (54275)

Decreased PGC-1α expression is associated with a hyperglycemia-induced increase in mitochondrial fragmentation and ROS generation. by Kaifeng Guo (296791)

(A) The intrinsic motivation about the reasoning task was decreased in the load condition than in the no-load condition after failure. by Michiko Sakaki (410314)

TNP increases while Gd³⁺ decreases BASIC activity in a dose-dependent manner. by Axel Schmidt (652713)

Cigarette smoke extract induced decrease of Spns2 expression in epithelial cells. by Hai B. Tran (573241)

Decreased trabecular bone mass in <i>Col1a1-Krm2</i> transgenic mice. by Jochen Schulze (365258)

Nectin-1 staining is decreased in HSV1-infected keratinocytes, but enhanced as a collar in surrounding uninfected cells. by Hafsa Rana (8201886)